| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/13/2006 | WO2006038007A2 Inhibitory analogues to block receptors for microbial pathogenic determinants |
| 04/13/2006 | WO2006037848A1 Method and preparation for binding aldehydes in saliva |
| 04/13/2006 | WO2006037811A2 Protracted exendin-4 compounds |
| 04/13/2006 | WO2006037800A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE |
| 04/13/2006 | WO2006037789A1 A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 04/13/2006 | WO2006037771A1 Pulmonary administration of an antithrombotic compound |
| 04/13/2006 | WO2006037744A1 Deglycosylated and desialidated long pentraxin ptx3 |
| 04/13/2006 | WO2006037188A1 Compositions and methods for inducing melanogenesis in a subject |
| 04/13/2006 | WO2006023971A3 Inhibition of mitogen-activated protein kinases in cardiovascular disease |
| 04/13/2006 | WO2006023684A3 Microprojection array patch for transdermal delivery of vascular endothelial growth factors |
| 04/13/2006 | WO2006023342A3 Synergistic conjugated linoleic acid (cla) and carnitine combination |
| 04/13/2006 | WO2006021451A3 Methods and compounds for treating diabetes |
| 04/13/2006 | WO2006017541A3 Antidiabetic oral insulin-biguanide combination |
| 04/13/2006 | WO2006012373A3 Combination therapies of hmgb and complement inhibitors against inflammation |
| 04/13/2006 | WO2006010515A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/13/2006 | WO2006007565A3 Cd40 variants skipping exon 5 |
| 04/13/2006 | WO2006006074A3 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 04/13/2006 | WO2006002646A3 Novel carbamylated epo and method for its production |
| 04/13/2006 | WO2005117952A3 Treatment methods utilizing albumin-binding proteins as targets |
| 04/13/2006 | WO2005110460A3 Diagnosis and treatment methods related to aging, especially in muscle (14.1) |
| 04/13/2006 | WO2005097146A3 Dairy components effective for fat loss |
| 04/13/2006 | WO2005083068A3 Methods for obtaining thermostable enzymes, dna polymerase i variants from thermus aquaticus having new catalytic activities, methods for obtaining the same, and applications to the same |
| 04/13/2006 | WO2005077411A3 Composition and method for the treatment of carcinoma |
| 04/13/2006 | WO2005077397A3 Methods and compositions for treating vascular diseases |
| 04/13/2006 | WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/13/2006 | WO2004032837A3 The use of cytokine able to bind il-18bp and of inhibiting the activity of a second cytokine |
| 04/13/2006 | WO2004009769A3 COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS |
| 04/13/2006 | WO2004003147A3 Cngh0004 polypeptides, antibodies, compositions, methods and uses |
| 04/13/2006 | US20060080744 Novel chemokine-like polypeptides |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079671 Contacting an optionally alkylated (especially carboxymethylated) aspartate-based resin having a tetradentate ligand with a with a with a 3+ metal ion source in the presence of acetic acid and removing non-complexed metal ion; product may stabilized with an alkanedicarboxylic acid |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079668 Junctional adhesion molecule splice variants |
| 04/13/2006 | US20060079512 10-farnesyl-4,6,8-tri(bisbenzyloxyphosphoryloxy)-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one; antitumor, anticarcinogenic agent; solid (pancreatic, prostate, colorectal, lung, ovarian cancer) or hematopoietic (leukemia or lymphoma) neoplasm; bactericide, inhibitor of 5-lipoxygenase, cyclooxygenase-2 |
| 04/13/2006 | US20060079509 Antineoplastic agents; inhibitors of cancer cell growth, mammalian lipoxygenase, acute and chronic inflammation |
| 04/13/2006 | US20060079499 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 04/13/2006 | US20060079488 Methods of treating and preventing bone loss |
| 04/13/2006 | US20060079484 Antithrombotic effect |
| 04/13/2006 | US20060079477 High affinity nucleic acid ligands of complement system proteins |
| 04/13/2006 | US20060079470 Combined dna vaccine and biological modifiers for cancer therapy |
| 04/13/2006 | US20060079463 Anticancer compositions comprising methenamine |
| 04/13/2006 | US20060079462 Organoselenium compounds for cancer chemoprevention |
| 04/13/2006 | US20060079461 Treatment of multiple myeloma by inhibition of p38 MAP kinase |
| 04/13/2006 | US20060079460 Purified LH |
| 04/13/2006 | US20060079459 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins |
| 04/13/2006 | US20060079458 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 04/13/2006 | US20060079457 BAFF, inhibitors thereof and their use in the modulation of B-cell response |
| 04/13/2006 | US20060079456 Vasoactive intestinal polypeptide pharmaceuticals |
| 04/13/2006 | US20060079455 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 04/13/2006 | US20060079454 Peptide nanostructures and methods of generating and using the same |
| 04/13/2006 | US20060079453 Hla binding peptides and their uses |
| 04/13/2006 | US20060079452 Administering anakinra |
| 04/13/2006 | US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same |
| 04/13/2006 | US20060079450 Polypeptide that does not include an N-linked glycosylation site such as interleukin-11 stabilized with hydroxyethyl starch and a disaccharide such as trehalose and sucrose; stable for at least 9 months when stored at 60 degrees C. |
| 04/13/2006 | US20060079449 Inhibition of Smad3 to prevent fibrosis and improve wound healing |
| 04/13/2006 | US20060079448 Compounds and methods for increasing neurogenesis |
| 04/13/2006 | US20060079447 Stabilized A-beta protofibrillar aggregates |
| 04/13/2006 | US20060079446 Methods and compositions for treating hypercholesterolemia |
| 04/13/2006 | US20060079445 CaMKII/calcium channel binding-related compositions and methods |
| 04/13/2006 | US20060079444 Human Sef isoforms and methods of using same for cancer gene therapy |
| 04/13/2006 | US20060079443 Methods and uses of leptin in immune modulation |
| 04/13/2006 | US20060079442 Methods and uses of leptin in immune modulation and hepatocellular carcinoma |
| 04/13/2006 | US20060079441 Methods of modulating angiogenesis |
| 04/13/2006 | US20060079440 Treatment of hi-virus infections with oxidised blood proteins |
| 04/13/2006 | US20060079439 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| 04/13/2006 | US20060078975 Crystal structure of enzyme and uses thereof |
| 04/13/2006 | US20060078969 Regulated transcription of targeted genes and other biological events |
| 04/13/2006 | US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078966 IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078963 Methods for producing modified glycoproteins |
| 04/13/2006 | US20060078959 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers |
| 04/13/2006 | US20060078957 A host cell containing an expression vector for an aggrecanase to use as a drug screening agent for joint diseases |
| 04/13/2006 | US20060078956 Methods to identify compounds that modulate rage |
| 04/13/2006 | US20060078947 Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 1521, 6662, 13913, 12405 or 5014 |
| 04/13/2006 | US20060078944 Methods and reagents relating to inflammation and apoptosis |
| 04/13/2006 | US20060078943 Method for obtaining anti-idiotype antibodies |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078933 Identifying a modulator of IL-17 receptor-like polypeptide activity; drug screening; treating inflammation |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078874 Use of nuclear hormone receptors |
| 04/13/2006 | US20060078629 Nutritional compositions and use thereof |
| 04/13/2006 | US20060078624 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078575 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 04/13/2006 | US20060078572 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |
| 04/13/2006 | US20060078571 Methods for treating inflammation pain |
| 04/13/2006 | US20060078568 Use of the residues from wine production |
| 04/13/2006 | US20060078567 Method of preventing acute pulmonary cell injury |
| 04/13/2006 | US20060078563 Using heat shock proteins to increase immune response |
| 04/13/2006 | US20060078558 Diagnosis, prognosis and treatment of pulmonary diseases |
| 04/13/2006 | US20060078555 Intraventricular hemorrhage thrombolysis |
| 04/13/2006 | US20060078554 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 04/13/2006 | US20060078553 Diverse multi-unit complexes including a tRNA synthetase fragment |
| 04/13/2006 | US20060078552 Hybrid and single chain meganucleases and use thereof |
| 04/13/2006 | US20060078551 Polynucleotide that encodes a polypeptide having activity as a phospholipase A2 inhibitor; especially obtained from the liver of a species of Python |
| 04/13/2006 | US20060078550 Porcine fgl2 |
| 04/13/2006 | US20060078549 Method of ameliorating or abrogating the effects of a neurodegenerative disorder, such as huntington's disease, by using coenzyme Q10 |
| 04/13/2006 | US20060078540 Dendritic cell nodes |